210 related articles for article (PubMed ID: 36479200)
1. Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis.
Oh BC; Lee JE; Nam JH; Hong JY; Kwon SH; Lee EK
Front Pharmacol; 2022; 13():908837. PubMed ID: 36479200
[No Abstract] [Full Text] [Related]
2. Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.
Haridoss M; Bagepally BS; Natarajan M
Int J Rheum Dis; 2021 Mar; 24(3):314-326. PubMed ID: 33486900
[TBL] [Abstract][Full Text] [Related]
3. Health related quality of life in adults with asthma: a systematic review to identify the values of EQ-5D-5L instrument.
Afshari S; Ameri H; Daroudi RA; Shiravani M; Karami H; Akbari Sari A
J Asthma; 2022 Jun; 59(6):1203-1212. PubMed ID: 33863264
[TBL] [Abstract][Full Text] [Related]
4. Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.
Joundi RA; Adekanye J; Leung AA; Ronksley P; Smith EE; Rebchuk AD; Field TS; Hill MD; Wilton SB; Bresee LC
J Am Heart Assoc; 2022 Jul; 11(13):e024296. PubMed ID: 35730598
[TBL] [Abstract][Full Text] [Related]
5. Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis.
Feng J; Zhang K; Dou L; Shi Z; Chen G; Li S
Qual Life Res; 2024 Jun; ():. PubMed ID: 38824212
[TBL] [Abstract][Full Text] [Related]
6. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
[TBL] [Abstract][Full Text] [Related]
7. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
8. Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis.
Redenz G; Ibaceta MC; Aceituno D; Balmaceda C; Espinoza MA
Value Health Reg Issues; 2023 Mar; 34():14-22. PubMed ID: 36371899
[TBL] [Abstract][Full Text] [Related]
9. Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis.
Yang Z; Li S; Wang X; Chen G
J Dermatolog Treat; 2022 Mar; 33(2):1029-1036. PubMed ID: 32716651
[TBL] [Abstract][Full Text] [Related]
10. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
11. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life among patients with gallstone disease: a systematic review and meta-analysis of EQ-5D utility scores.
Deborah YA; Haridoss M; Natarajan M; Joshua V; Bagepally BS
Qual Life Res; 2022 Aug; 31(8):2259-2266. PubMed ID: 35031978
[TBL] [Abstract][Full Text] [Related]
13. Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.
Kularatna S; Chen G; Byrnes J; Scuffham PA
Value Health Reg Issues; 2017 May; 12():20-23. PubMed ID: 28648311
[TBL] [Abstract][Full Text] [Related]
14. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
15. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
[TBL] [Abstract][Full Text] [Related]
17. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis.
Kim H; Cook G; Goodall S; Liew D
Pharmacoecon Open; 2021 Sep; 5(3):459-467. PubMed ID: 33891268
[TBL] [Abstract][Full Text] [Related]
18. Comparing and transforming PROMIS utility values to the EQ-5D.
Hartman JD; Craig BM
Qual Life Res; 2018 Mar; 27(3):725-733. PubMed ID: 29264776
[TBL] [Abstract][Full Text] [Related]
19. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
20. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
